Ceva launches new Carprodyl Quadri pain therapy for dogs

Ceva has announced the launch of Carprodyl Quadri, a new carprofen-based pain therapy for dogs.

The product is indicated for the reduction of inflammation and pain caused by musculoskeletal disorders and degenerative joint disease in canines, as well as for the management of postoperative pain.

The pork-flavoured four-way break tablets are available in two presentations of 50mg and 120mg, with each tablet offering four dosage strengths, making it easier to tailor the dose to accurately reflect a dog's weight.

Moreover, unused tablet portions can be kept in the blister pack for up to 72 hours, thereby reducing wastage.

A range of marketing materials are being provided to veterinary practices to coincide with the launch, including dosage charts, dispensing envelopes, reminder stickers and cards, and client letters explaining why their prescription has changed.

Lucy Vernon, product manager at Ceva Animal Health, said: "Carprodyl Quadri is an easy-to-administer carprofen that provides accurate dosing while reducing cost and waste, and is a welcome addition to our popular pain management portfolio."

With over 20 years of experience within the animal health market, we at Zenopa have the knowledge, skills and expertise to help find the right job for you. To find out more about the current animal health roles we have available, you can search for the latest job roles, register your details, or contact the team today.